Midday movers: Nike and Accolade fall; Humana and Infinera rise

Go back to Midday movers: Nike and Accolade fall; Humana and Infinera rise

Argus Reiterates Hold Rating on Nike (NKE)

July 1, 2024 1:10 PM EDT

Argus analyst John Staszak reiterated a Hold rating on Nike (NYSE: NKE).

The analyst comments " Weakening demand We remain concerned about Nikes $7.5 billion in inventory. The company will need to cut prices to clear this inventory, which will weigh on margins and earnings in... More

Nike (NKE) PT cut to $89 at CFRA (correction)

June 28, 2024 9:33 AM EDT

(Updated - June 29, 2024 6:18 AM EDT)

CFRA analyst Zachary Warring cut the price target on Nike (NYSE: NKE) to $89.00 (from $95.00) while maintaining a Hold rating.

The analyst comments "We lower our 12-month price target by $6 to $89, based on 25.5x our FY 25 (May) EPS... More